NRA-Amlodipine 5 mg tablets: One lot recalled as some bottles may contain the wrong drug

Product safety

Date

2025-07-07

Country

Canada

Product

NRA-Amlodipine 5 mg, DIN 02476460

Category

Drugs & medical

Source

Health Canada

Copied automatically from the Government of Canada. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

1. Check the product name, strength and lot number against the official notice.
2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the Government of Canada has the exact models, batch codes and remedy, and it takes priority.

Other drugs & medical recalls in Canada

1. 2025-07-09
2. CA
   Drugs & medicalType II

   EVair

   Performance

   Health CanadaOfficial notice →
3. 2025-07-08
4. CA
   Drugs & medicalType I

   NRA-AMLODIPINE 5MG: Affected lot may contain tablet(s) of Metoprolol Succinate prolonged–release 12.5 mg tablets

   Product safety

   Health CanadaOfficial notice →
5. 2025-07-07
6. CA
   Drugs & medicalType II

   Anesketin : Presence of particulate matter in the affected lots

   Product quality

   Health CanadaOfficial notice →
7. 2025-07-04
8. CA
   Drugs & medicalType II

   Biofinity® Toric Multifocal and XR Toric

   Labelling and packaging - Sterility

   Health CanadaOfficial notice →
9. CA
   Drugs & medicalType I

   PMS-Methylphenidate CR 10 mg capsule; exceed the acceptable intake limit for N-nitroso-methylphenidate

   Product quality

   Health CanadaOfficial notice →
10. CA
    Drugs & medicalType II

    CONTOUR® NEXT GEN Blood Glucose Monitoring System

    Performance

    Health CanadaOfficial notice →